If findings from the recent studies are anything to go by, then individuals will no longer need to worry about aging. According to an article published in the impact journals, rapamycin analog is the new answer to improving immunity in aged individuals. According to Mikhail Blagosklonny, the publisher of the article, there has been a long belief that aging was a functional decline that is caused by the accumulation of random molecular damage, which scientist believes that it cannot be prevented.
According to the recent scientific developments, Mikhail Blagosklonny believes that breaking this dogma, hyper function theory that describes aging as a continuation of growth can be used in humans to treat aging and also prevent the occurrence of various illnesses. He believes that when administered in proper doses and schedule, rapamycin and other rapalogs can extend the life span of human beings. The news that rapamycin analog improves immunity in older people made sensational headlines all over the world. Finally, there seems to be an answer to a question that has been lingering in the minds of individuals over the years concerning the solution to aging. Most people want to look younger for a long time. Many people don’t want to age because aging has been associated with various health conditions like cancer, memory loss and even loss of eyesight.
The word about the use rapamycin has been doing rounds for several years now, and in 2006, it was concluded that the drug was already approved for clinical use and it was available in the stores. Besides being applied in the treatment of cancer, rapamycin can also be used to treat cardiovascular diseases, metabolic disorders, autoimmunity, and all other diseases that are associated with aging. Rapamycin has been labeled as the best drug for use in the fight against senescence and aging in human beings. Visit ResearchGate.Net to know more about Mikhail’s latest work.
Mikhail Blagosklonny also notes that rapamycin is safe, non-toxic free drug that can be used for everyday oral administration. It can be administered daily to patients undergoing transplants for several years. He says that drug helps in transforming individuals’ immunity.
About Mikhail Blagosklonny
Mikhail Blagosklonny is a renowned professor of oncology who serves at the Roswell Park Cancer Institute. He has spent much of time studying aging and cancer. Mikhail has made significant contributions in the area.
Professor Mikhail attended the First Pavlov State Medical University of St. Petersburg where he received an MD in international medicine. Professor Mikhail Blagosklonny also earned his Ph.D. in Experimental Medicine and Cardiology from the same university. He has served in high-ranking positions in a host of organizations where he has mostly been involved in research work and conducting scientific experiments. View Mikhail’s profile on Google Scholar